- Home
- UBCP vs HLVX Comparison
UBCP vs HLVX Comparison
Compare UBCP & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBCP
- HLVX
- Stock Information
- Founded
- UBCP 1902
- HLVX 2020
- Country
- UBCP United States
- HLVX United States
- Employees
- UBCP N/A
- HLVX N/A
- Industry
- UBCP Major Banks
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- UBCP Finance
- HLVX Health Care
- Exchange
- UBCP Nasdaq
- HLVX Nasdaq
- Market Cap
- UBCP 77.3M
- HLVX 87.6M
- IPO Year
- UBCP N/A
- HLVX 2022
- Fundamental
- Price
- UBCP $12.84
- HLVX $1.83
- Analyst Decision
- UBCP
- HLVX Hold
- Analyst Count
- UBCP 0
- HLVX 5
- Target Price
- UBCP N/A
- HLVX $2.33
- AVG Volume (30 Days)
- UBCP 6.9K
- HLVX 130.0K
- Earning Date
- UBCP 11-06-2024
- HLVX 11-07-2024
- Dividend Yield
- UBCP 5.54%
- HLVX N/A
- EPS Growth
- UBCP N/A
- HLVX N/A
- EPS
- UBCP 1.36
- HLVX N/A
- Revenue
- UBCP $29,229,619.00
- HLVX N/A
- Revenue This Year
- UBCP N/A
- HLVX N/A
- Revenue Next Year
- UBCP $8.94
- HLVX N/A
- P/E Ratio
- UBCP $9.42
- HLVX N/A
- Revenue Growth
- UBCP N/A
- HLVX N/A
- 52 Week Low
- UBCP $10.38
- HLVX $1.55
- 52 Week High
- UBCP $15.50
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- UBCP 48.94
- HLVX 44.81
- Support Level
- UBCP $12.03
- HLVX $1.80
- Resistance Level
- UBCP $13.05
- HLVX $2.02
- Average True Range (ATR)
- UBCP 0.39
- HLVX 0.08
- MACD
- UBCP -0.05
- HLVX -0.00
- Stochastic Oscillator
- UBCP 59.44
- HLVX 13.95
About UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. The company's primary deposit products are checking, savings and term certificate accounts and its primary lending products are residential mortgages, commercial and installment loans. The company serves customers mainly located in Athens, Belmont, Carroll, Fairfield, Harrison, Jefferson and Tuscarawas Counties in Ohio and Marshall and Ohio Counties in West Virginia and the surrounding localities in northeastern, east-central and southeastern Ohio and include a wide range of individuals, businesses and other organizations.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.